Clinical Trials Browser

Available × Pancreatic Ductal Adenocarcinoma (PDAC) × Clear all

NCT07612930 2026-05-29

Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)